PEPTIDES DERIVED FROM TUMOR REJECTION ANTIGEN PRECURSORS AND PRESENTED BY HLA-B44 USEFUL IN DIAGNOSTIC AND THERAPEUTIC METHODOLOGIES

摘要

Tumor rejection antigens presented by HLA-B44 molecules are described. These peptides are useful in diagnostic and therapeutic methodologies. The tumor rejection antigens are not derived from tyrosinase, which has previously been identified as a tumor rejection antigen precursor processed to an antigen presented by HLA-B44.